𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Glycogen synthase kinase-3β and tau genes interact in Parkinson's and Alzheimer's diseases

✍ Scribed by Inés García-Gorostiaga; Pascual Sánchez-Juan; Ignacio Mateo; Eloy Rodríguez-Rodríguez; Coro Sánchez-Quintana; Soraya Curiel del Olmo; José Luis Vázquez-Higuera; José Berciano; Onofre Combarros; Jon Infante

Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
86 KB
Volume
65
Category
Article
ISSN
0364-5134

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Glycogen synthase kinase-3β and tau gene
Glycogen synthase kinase-3β and tau genes interact in Alzheimer's disease
✍ John B. J. Kwok; Clement T. Loy; Gillian Hamilton; Edmond Lau; Marianne Hallupp; 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 258 KB

## Abstract ## Objective We examined the epistatic effect between haplotypes of __glycogen synthase kinase__‐__3__β (__GSK3B__) gene and __microtubule__‐__associated protein Tau__ (__MAPT__) gene in Alzheimer's disease (AD). ## Methods A genetic association study of three AD cohorts was made. Li

Interaction between the ADAM12 and SH3MD
Interaction between the ADAM12 and SH3MD1 genes may confer susceptibility to late-onset Alzheimer's disease
✍ D. Harold; L. Jehu; D. Turic; P. Hollingworth; P. Moore; P. Summerhayes; V. Mosk 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 75 KB 👁 2 views

## Abstract The neuropathology of Alzheimer's disease (AD) is characterized by intracellular neurofibrillary tangles and the extracellular deposition of β‐amyloid (Aβ) in senile plaques. Aβ has been shown to mediate neurodegenerative and inflammatory changes associated with amyloid plaques, althoug

Interaction of polymorphisms in the gene
Interaction of polymorphisms in the genes encoding interleukin-6 and estrogen receptor beta on the susceptibility to Parkinson's disease
✍ Anna Håkansson; Lars Westberg; Staffan Nilsson; Silvia Buervenich; Andrea Carmin 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB 👁 1 views

## Abstract The multifunctional cytokine interleukin‐6 (IL‐6) is involved in inflammatory processes in the central nervous system and increased levels of IL‐6 have been found in patients with Parkinson's disease (PD). It is known that estrogen inhibits the production of IL‐6, via action on estrogen